Author Question: The core of a long solenoid with 1000 turns/m and a current of 0. 5 A is filled with an unknown ... (Read 54 times)

gbarreiro

  • Hero Member
  • *****
  • Posts: 566
The core of a long solenoid with 1000 turns/m and a current of 0. 5 A is filled with an unknown material. It is found that the magnetic field along the axis of the solenoid increases by 0.0017.
 
  What is the magnetic susceptibility of the unknown material? A)
 
  1.7  10-5
  B)
 
  3.4  10-5
  C)
 
  0.0048
  D)
 
  -3.4  10-5
  E)
 
  0.0021

Question 2

A semicircular wire of radius R connects two straight wire segments. If a current I flows along the wire, the magnitude of the magnetic field at the center of the semicircular wire due to the current in the semicircular wire is
 
  A)
 
  O I/2R.
  B)
 
  O I/4R.
  C)
 
  O I/8R.
  D)
 
  O I/4R.
  E)
 
  O I/8R.



mochi09

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

A

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library